Hepatocellular carcinoma was treated with lncRNA PANDA, which reduced interleukin-8 (IL-8), allowing previously aged cells to continue to multiply and contribute to tumor growth [16]. This evidence concerns the gene CXCL8 and hepatocellular carcinoma.